Evidence map›Paper›PMID 40806204›Full record

ArticleInternational journal of molecular sciences2025

Functional

Daniela Alves Pereira, Marcelo Rizzatti Luizon, Ricardo Carvalho Cavalli, Jose Eduardo Tanus-Santos, Valéria Cristina Sandrim

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniela Alves PereiraDepartment of Physiology and Pharmacology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Distrito Rubiao Junior, Botucatu 18680-000, SP, Brazil.ORCID 0000-0001-5491-6709
Marcelo Rizzatti LuizonDepartment of Physiology and Pharmacology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Distrito Rubiao Junior, Botucatu 18680-000, SP, Brazil.
Ricardo Carvalho CavalliDepartment of Gynecology and Obstetrics, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto 14049-900, SP, Brazil.ORCID 0000-0001-5010-4914
Jose Eduardo Tanus-SantosDepartment of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Av. Bandeirantes, 3900, Ribeirao Preto 14049-900, SP, Brazil.ORCID 0000-0002-9945-9633
Valéria Cristina SandrimDepartment of Physiology and Pharmacology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Distrito Rubiao Junior, Botucatu 18680-000, SP, Brazil.

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/12010-7National Council for Scientific and Technological Development 308504/2021-6, and 444682/2024-4, 302614/2025-7, 301293/2018-0Universidade Estadual Paulista (Unesp) 05/2024 - Unesp Postdoctoral Program.
6 · The paper itself

Abstract

Preeclampsia (PE) shares common pathophysiological mechanisms with cardiovascular diseases, including endothelial dysfunction and exacerbated inflammatory response. Myeloperoxidase (MPO) has been suggested as a biomarker for cardiovascular risk, and its circulating levels are contradictory in PE. Elevated levels of MPO can promote host tissue damage and trigger vascular injury.

Indexed as

HaplotypesHypertension, Pregnancy-InducedPeroxidasePolymorphism, Single NucleotidePre-EclampsiaAdultCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansPregnancyMPO protein, humanPeroxidasegenetic polymorphismsMPOmyeloperoxidasepreeclampsia

Identifiers

PMID40806204
PMCPMC12345846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.